e.okafor

TL2 · Essen

Contributes reviews on supplier material. Based in Essen.

Joined 28 March 2025 · last posted 4d

71Posts here

1Topics

0Solutions

1kLikes received

1.5kLikes given

23Badges

214Days visited

4.6kPosts read

Recent activity

Full stream

Documenting a supplier's response to a discrepancy Replied, post #47 · Sourcing › Vendor reports · 24 Jul 2026 · 16 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #115 · Evidence › Journal club · 18 Jul 2026 · 32 likes Worth stating the null on SURMOUNT-OSA before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Revisiting: The best-written scientific paper you have read Replied, post #85 · Lounge › Off topic · 11 Jul 2026 · 22 likes Paper, same. I think it is that writing by hand is slow enough to make you decide what is worth recording.
Programming during a large energy deficit Replied, post #37 · Nutrition & Training › Resistance training · 11 Jul 2026 · 6 likes Programming during a large energy: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #24 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote. I am aware this is the third time this…
What to bring: records that a clinician can actually use — a second dataset Replied, post #8 · Clinical › Prescriber conversations · 5 Jul 2026 · 0 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #77 · Evidence › Journal club · 3 Jul 2026 · 3 likes Taking post #74 at face value and following it one step further. One caution on SURMOUNT-OSA: everything above assumes the underlying documentation is what it claims to…
Revisiting: The best-written scientific paper you have read Replied, post #66 · Lounge › Off topic · 2 Jul 2026 · 0 likes Taking best-written scientific paper seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #9 · Practice › Dosing & titration · 2 Jul 2026 · 1 like My understanding of four-week escalation interval is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #45 · Access › International · 29 Jun 2026 · 0 likes Post #43 and I disagree about the size of the effect, not about the direction. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #54 · Analytics › Home & field testing · 20 Jun 2026 · 8 likes Post #50 describes the usual case. This is about the unusual one. A methods point on Reflectance and photometric devices rather than a substantive one: if the…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #91 · Practice › Reconstitution · 20 Jun 2026 · 11 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…